{"log_id": 5418539384373353842, "direction": 0, "words_result_num": 30, "words_result": [{"probability": {"variance": 0, "average": 0.999619, "min": 0.999135}, "location": {"width": 214, "top": 107, "height": 52, "left": 717}, "words": "说明书"}, {"probability": {"variance": 0.00046, "average": 0.978242, "min": 0.940223}, "location": {"width": 100, "top": 100, "height": 31, "left": 1356}, "words": "第1/5页"}, {"probability": {"variance": 0.000462, "average": 0.974019, "min": 0.942611}, "location": {"width": 86, "top": 162, "height": 22, "left": 178}, "words": "2006100"}, {"probability": {"variance": 4.9e-05, "average": 0.995009, "min": 0.975732}, "location": {"width": 347, "top": 196, "height": 59, "left": 584}, "words": "胸腺五肽注射液处方"}, {"probability": {"variance": 2.4e-05, "average": 0.996018, "min": 0.987546}, "location": {"width": 132, "top": 301, "height": 38, "left": 198}, "words": "技术领域"}, {"probability": {"variance": 0.004086, "average": 0.980778, "min": 0.660763}, "location": {"width": 1064, "top": 310, "height": 93, "left": 253}, "words": "本发明涉及一种新的药物制剂,特别是涉及免疫调节药物胸腺五肽的一种注"}, {"probability": {"variance": 0.001957, "average": 0.982496, "min": 0.835561}, "location": {"width": 596, "top": 397, "height": 70, "left": 201}, "words": "射液制剂,它的处方、应用及其制备方法"}, {"probability": {"variance": 0.006153, "average": 0.95383, "min": 0.817969}, "location": {"width": 132, "top": 484, "height": 38, "left": 210}, "words": "背景技术"}, {"probability": {"variance": 0.003139, "average": 0.98453, "min": 0.676691}, "location": {"width": 1062, "top": 497, "height": 91, "left": 264}, "words": "胸腺五肽作为一种免疫调节药物在临床上已有多年应用历史,且前胸腺五肽"}, {"probability": {"variance": 0.000869, "average": 0.990981, "min": 0.838782}, "location": {"width": 1114, "top": 557, "height": 93, "left": 214}, "words": "主要以粉针形式为主,其配方中不含防腐剂。虽然胸腺五肽也有注射液制剂,但"}, {"probability": {"variance": 0.000175, "average": 0.992515, "min": 0.946603}, "location": {"width": 1114, "top": 618, "height": 93, "left": 216}, "words": "由于胸腺五肽不稳定,需要加入防腐剂使其稳定化。对于药物制剂而言,在使用"}, {"probability": {"variance": 0.001057, "average": 0.991771, "min": 0.806659}, "location": {"width": 1116, "top": 682, "height": 91, "left": 219}, "words": "的方便性上注射液水针要优于注射粉针。但由于胸腺五肽注射液的处方中含有防"}, {"probability": {"variance": 0.00029, "average": 0.991414, "min": 0.928673}, "location": {"width": 1114, "top": 742, "height": 93, "left": 221}, "words": "腐剂,带来了一定的不良反应,为此开发一种使用方便的胸腺五肽注射液制剂同"}, {"probability": {"variance": 0.010718, "average": 0.964655, "min": 0.59637}, "location": {"width": 463, "top": 833, "height": 63, "left": 223}, "words": "时避免副作用,对患者是有利的"}, {"probability": {"variance": 3e-06, "average": 0.998704, "min": 0.992224}, "location": {"width": 1027, "top": 865, "height": 89, "left": 317}, "words": "般认为不使用防腐剂将对胸腺五肽药物的稳定性产生不良影响,目前尚未"}, {"probability": {"variance": 7.3e-05, "average": 0.9947, "min": 0.964538}, "location": {"width": 845, "top": 941, "height": 77, "left": 230}, "words": "有不使用防腐剂就可解决胸腺五肽水针注射剂稳定性的报道"}, {"probability": {"variance": 0.001859, "average": 0.972302, "min": 0.89772}, "location": {"width": 134, "top": 1039, "height": 38, "left": 237}, "words": "发明内容"}, {"probability": {"variance": 1.1e-05, "average": 0.997867, "min": 0.986813}, "location": {"width": 1034, "top": 1052, "height": 89, "left": 294}, "words": "本发明提供一种胸腺五肽注射液制剂,该注射液制剂的配方中不含防腐剂"}, {"probability": {"variance": 0.000283, "average": 0.993454, "min": 0.905929}, "location": {"width": 1027, "top": 1114, "height": 86, "left": 308}, "words": "本发明的注射剂,是由药物活性成分胸腺五肽和药物可接受的载体制成的"}, {"probability": {"variance": 0.00011, "average": 0.996569, "min": 0.939327}, "location": {"width": 1050, "top": 1176, "height": 91, "left": 246}, "words": "所述药物可接受的载体包括注射用的液体介质、渗透压调节剂、pH调节剂"}, {"probability": {"variance": 0.003284, "average": 0.983453, "min": 0.678096}, "location": {"width": 1032, "top": 1237, "height": 86, "left": 308}, "words": "本发明的注射液制剂,是药学上可以接受的注射剂型,可以是水针、输液"}, {"probability": {"variance": 0.000229, "average": 0.990707, "min": 0.957135}, "location": {"width": 203, "top": 1338, "height": 50, "left": 253}, "words": "注射用浓溶液"}, {"probability": {"variance": 0.000439, "average": 0.99004, "min": 0.889748}, "location": {"width": 1052, "top": 1356, "height": 93, "left": 317}, "words": "本发明的注射液制剂,其给药途径可以是:皮下注射、肌肉注射、静脉注射"}, {"probability": {"variance": 0.000286, "average": 0.984771, "min": 0.958164}, "location": {"width": 169, "top": 1461, "height": 50, "left": 260}, "words": "或静脉滴注"}, {"probability": {"variance": 0.000123, "average": 0.995274, "min": 0.941362}, "location": {"width": 1052, "top": 1480, "height": 93, "left": 326}, "words": "本发明的注射液制剂,在使用时可以和其他注射用液体制剂合用,如加入到"}, {"probability": {"variance": 0.003725, "average": 0.984888, "min": 0.631456}, "location": {"width": 1116, "top": 1546, "height": 89, "left": 264}, "words": "这些制剂中注射。以上使用方法中,可使用等漆注射溶液,根据临床需要,这些"}, {"probability": {"variance": 0.001031, "average": 0.989165, "min": 0.810965}, "location": {"width": 1110, "top": 1605, "height": 91, "left": 271}, "words": "等渗注射溶液可选自0.9%的氯化钠注射液、5%的葡萄糖注射液、5%的甘露醇注"}, {"probability": {"variance": 0.002791, "average": 0.984494, "min": 0.725194}, "location": {"width": 1080, "top": 1671, "height": 89, "left": 271}, "words": "射液、5%的山梨醇注射液、2.1%的甘氨酸注射液或其他等渗注射溶液中的任"}, {"probability": {"variance": 0, "average": 0.999984, "min": 0.999984}, "location": {"width": 36, "top": 1783, "height": 34, "left": 278}, "words": "种"}, {"probability": {"variance": 0.000234, "average": 0.992438, "min": 0.923202}, "location": {"width": 1057, "top": 1797, "height": 84, "left": 335}, "words": "本发明的注射剂为液体注射剂,作为液体注射剂,溶剂为水、醇或它们的混"}], "language": 3}